Kinarus Therapeutics Holding AG announced that it has engaged Great Health Companion Group Ltd, a subsidiary of Hakim Unique Group, a global conglomerate from China, to explore partnering options to initiate Phase 2 testing of KIN001 to treat wet age-related macular degeneration and idiopathic pulmonary fibrosis.
November 16, 2022
· 4 min read